Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Sonnet BioTherapeutics Holdings, Inc.v352665_ex99-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): August 12, 2013

 

CHANTICLEER HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

________________

 

Delaware 000-29507 20-2932652
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification)

  

11220 Elm Lane, Suite 203, Charlotte, NC 28277

(Address of principal executive office) (zip code)

 

___________________________________________________

(Former address of principal executive offices) (zip code)

 

(704) 366-5122
(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))

 
 

 

ITEM 2.02. Results of Operations and Financial Condition.

 

On August 12, 2013, Chanticleer Holdings, Inc. issued a press release announcing its 2013 second quarter and year-to-date financial results. A copy of the press release is furnished not filed as Exhibit 99.1 hereto.

 

ITEM 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1 Press release dated August 12, 2013.

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 12, 2013

 

  Chanticleer Holdings, Inc.
   
  By: /s/  Michael D. Pruitt
    Michael D. Pruitt
    Chief Executive Officer

 

 
 

EXHIBIT INDEX

 

Exhibit No. Description Manner of Filing
99.1 Press Release dated August 12, 2013 Furnished Electronically